Anti-hCD14 (Clone: RPA-M1 ) FITC Conjugated

Anti-hCD14 (Clone: RPA-M1 ) FITC Conjugated
%
Rabattaktion
Aktion:

Erhalten Sie 15% Rabatt auf Antikörper und Biosimilars von Abeomics!

*1
*1 Angebot gültig bis zum 30.06.2024
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Rabatt Preis
ABE-10-4077-F-100 100 µg -

3 - 11 Werktage*

15 %
205,00 €
174,25 €
 
CD14 antigen is a GPI (Glycosyl-Phosphatidylinositol)-linked glycoprotein and has been shown to... mehr
Produktinformationen "Anti-hCD14 (Clone: RPA-M1 ) FITC Conjugated"
CD14 antigen is a GPI (Glycosyl-Phosphatidylinositol)-linked glycoprotein and has been shown to be critically important in the signaling pathways of TLR (Toll-like receptor). CD14 expression in BC (Bladder Cancer) subpopulation of cancer cells is required for increased cytokine production and increased tumor growth. Furthermore, tumors formed by CD14-high cells are more highly vascularized with higher myeloid cell infiltration. Inflammatory factors produced by CD14-high BC cells recruit and polarize monocytes and macrophages to acquire immune-suppressive characteristics. CD14 is located on the surface of immune response cells in the lungs as well as other organs. Both TLR4 and CD14 genes are codependent with MD2 in their roles as signalers of other mediators in the innate response to pathogens. It has a central role in innate immunity, as it can interact with several ligands, including LPS from gram-negative bacteria, components from gram-positive bacteria, fungi, and viruses. CD14 has also been suspected to be a crucial link between innate and adaptive immunity in response to environmental antigens. Protein function: Coreceptor for bacterial lipopolysaccharide (PubMed:1698311, PubMed:23264655). In concert with LBP, binds to monomeric lipopolysaccharide and delivers it to the LY96/TLR4 complex, thereby mediating the innate immune response to bacterial lipopolysaccharide (LPS) (PubMed:20133493, PubMed:23264655). Acts via MyD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:8612135). Acts as a coreceptor for TLR2:TLR6 heterodimer in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in response to triacylated lipopeptides, these clusters trigger signaling from the cell surface and subsequently are targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Binds electronegative LDL (LDL(-)) and mediates the cytokine release induced by LDL(-) (PubMed:23880187). [The UniProt Consortium]
Schlagworte: Anti-CD14, Monoclonal antibody to hCD14 (Clone: RPA-M1 ) FITC Conjugated
Hersteller: Abeomics
Hersteller-Nr: 10-4077-F

Eigenschaften

Anwendung: FC
Antikörper-Typ: Monoclonal
Klon: RPA-M1
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human
Immunogen: Human PHA-stimulated PBMC were used as an immunogen for this antibody.
Format: Purified

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-hCD14 (Clone: RPA-M1 ) FITC Conjugated"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen